Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
July 2, 2001
- Dainippon Launches Gasmotin in China
July 2, 2001
- OTC NEWS IN BRIEF
July 2, 2001
- EAD Director Urges Generic Houses to Expand Their Sales Route
July 2, 2001
- Takeda to Invest \110 Billion in R&D for FY2001
July 2, 2001
- 14 New Ingredients Officially Clear Regulatory Approval
July 2, 2001
- Long-term Continuous Use of Rocornal Reduces Cardiac Events
July 2, 2001
- Adalat Inhibits Carotid Artery Thickening: INSIGHT Side-arm Study
July 2, 2001
- Kirin, Corixa to Jointly Develop Antibody Drugs by Using TC Mouse
July 2, 2001
- BUSINESS NEWS IN BRIEF -2-
July 2, 2001
- 2001 Novartis Foundation Grant for Gerontological Research Goes to 5 People
July 2, 2001
- BUSINESS NEWS IN BRIEF -1-
July 2, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 2, 2001
- China, Taiwan Added to Servier's Territory for Kissei's Mitiglinide
July 2, 2001
- Fresenius Medical Care to Become Major Player in Japan: President van Hest
July 2, 2001
- Physicians Should Also Be Forbidden to Receive Gifts: Maker FTC
July 2, 2001
- REGULATORY NEWS IN BRIEF
July 2, 2001
- Bayer AG to Increase Share in Asia-Pacific from 16% to 25%
July 2, 2001
- Japan Is Lagging Behind the US in Life Science: S&T White Paper
July 2, 2001
- M&A, Alliance Effective for Strengthening R&D Ability: EAD Director
July 2, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…